These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21554436)

  • 21. Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial.
    Senti G; Johansen P; Haug S; Bull C; Gottschaller C; Müller P; Pfister T; Maurer P; Bachmann MF; Graf N; Kündig TM
    Clin Exp Allergy; 2009 Apr; 39(4):562-70. PubMed ID: 19226280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Allergen-specific immunotherapy or desensitization].
    Demoly P; Michel FB
    Bull Acad Natl Med; 2009 May; 193(5):1127-44; discussion 1144-5. PubMed ID: 20120392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Specific immunotherapy--past--present--future].
    Kägi MK
    Praxis (Bern 1994); 1998 Sep; 87(40):1330-4. PubMed ID: 9816927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specific immunotherapy, one century later.
    Passalacqua G; Bush RK
    Curr Opin Allergy Clin Immunol; 2011 Dec; 11(6):551-3. PubMed ID: 21971328
    [No Abstract]   [Full Text] [Related]  

  • 25. Novel ways for immune intervention in immunotherapy: mucosal allergy vaccines.
    Mascarell L; Van Overtvelt L; Moingeon P
    Immunol Allergy Clin North Am; 2006 May; 26(2):283-306, vii-viii. PubMed ID: 16701145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
    Durham SR; Yang WH; Pedersen MR; Johansen N; Rak S
    J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [New administration routes for immunotherapy].
    Martorell Aragonés A
    Allergol Immunopathol (Madr); 2000; 28(3):93-102. PubMed ID: 10867377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Future forms of immunotherapy.
    Casale TB; Stokes JR
    J Allergy Clin Immunol; 2011 Jan; 127(1):8-15; quiz 16-7. PubMed ID: 21094518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation.
    Möbs C; Slotosch C; Löffler H; Jakob T; Hertl M; Pfützner W
    J Immunol; 2010 Feb; 184(4):2194-203. PubMed ID: 20048125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 100 years of immunotherapy: the Monaco charter. under the high patronage of His Serene Highness Prince Albert II of Monaco.
    Canonica GW; Baena-Cagnani CE; Compalati E; Bohle B; Bonini S; Bousquet J; Cox L; Fink-Wagner AH; González Díaz S; Jacobsen L; Passalacqua G; Pawankar R; Vieths S; Yusuf O; Zuberbier T
    Int Arch Allergy Immunol; 2013; 160(4):346-9. PubMed ID: 23183050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunotherapy coming of age: notable advances during the first hundred years.
    Nelson HS
    Expert Rev Clin Immunol; 2017 May; 13(5):389-392. PubMed ID: 28443797
    [No Abstract]   [Full Text] [Related]  

  • 32. Long-term allergen-specific immunotherapy correlates with long-term allergen-specific immunological tolerance.
    Ali I; Goksal K; Ozan B; Gulsen D
    Adv Ther; 2008 Jan; 25(1):29-36. PubMed ID: 18224290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oralair Birch, a recombinant major birch pollen allergen tablet for sublingual immunotherapy of allergic rhinitis caused by birch pollen.
    Larenas-Linnemann D
    Curr Opin Investig Drugs; 2010 May; 11(5):586-96. PubMed ID: 20419605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in allergen-specific immunotherapy.
    Passalacqua G; Compalati E; Canonica GW
    Curr Drug Targets; 2009 Dec; 10(12):1255-62. PubMed ID: 19909232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The future of sublingual immunotherapy.
    Marcucci F; Duse M; Frati F; Incorvaia C; Marseglia GL; La Rosa M
    Int J Immunopathol Pharmacol; 2009; 22(4 Suppl):31-3. PubMed ID: 19944008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of allergy to new aeroallergens during specific immunotherapy (SIT) in grass pollen sensitive patients.
    Obtulowicz K; Cichocka-Jarosz E
    Allerg Immunol (Paris); 1998 Oct; 30(8):250-4. PubMed ID: 9846194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of immunmodulators in allergen-specific immunotherapy.
    Kopp MV
    Allergy; 2011 Jun; 66(6):792-7. PubMed ID: 21332502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allergen-specific immunotherapy in allergic rhinitis and asthma. Mechanisms and proof of efficacy.
    Pipet A; Botturi K; Pinot D; Vervloet D; Magnan A
    Respir Med; 2009 Jun; 103(6):800-12. PubMed ID: 19216064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allergy immunotherapy: the first 100 years.
    Firschein DE
    J Med Assoc Ga; 2014; 103(1):32. PubMed ID: 24851491
    [No Abstract]   [Full Text] [Related]  

  • 40. Advances in upper airway diseases and allergen immunotherapy in 2007.
    Saltoun C; Avila PC
    J Allergy Clin Immunol; 2008 Sep; 122(3):481-7. PubMed ID: 18694591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.